Overview
The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate
Status:
Completed
Completed
Trial end date:
2020-07-09
2020-07-09
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
Perioperative bleeding is the most common complication related to transurethral resection of prostate, the aim of the study is to compare the effect of pre-operative use of finasteride versus Cyproterone acetate on blood loss with mono polar TURPPhase:
Early Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Benha UniversityTreatments:
Cyproterone
Cyproterone Acetate
Finasteride
Criteria
Inclusion Criteria:- Patients with benign prostatic hyperplasia with prostate size (60-100) grams
- Lower urinary tract symptoms (LUTS) not responding to medical treatment
- Recurrent prostatic bleeding
- Recurrent acute urinary retention
- Chronic urinary retention
Exclusion Criteria:
- Patients with coagulation disorders
- Previous prostatic surgery
- Previous finasteride administration
- Bladder pathology (urinary bladder stones - bladder mass)
- Suspected or proved cancer prostate
- Hepatic or renal impairment
- Patients unfit for operation eg. Decompensated heart failure, poor chest condition